Nitrogencontaining bicyclic hetroaryl compounds for the treatment of Raf protein kinase-mediated diseases

Details for Australian Patent Application No. 2006330888 (hide)

Owner Amgen Inc.

Inventors Retz, Daniel M.; Petkus, Jeffrey; Zhu, Jiawang; Tasker, Andrew; Chen, Jian J.; Nixey, Thomas; Doherty, Elizabeth M.; Liu, Gang; Smith, Adrian L.; Huang, Qi; De Morin, Frenel F.; Hitchcock, Stephen; Paras, Nick A.; Kim, Joseph L.

Agent Shelston IP

Pub. Number AU-B-2006330888

PCT Pub. Number WO2007/076092

Priority 11/643,261 20.12.06 US; 60/753,705 23.12.05 US

Filing date 22 December 2006

Wipo publication date 5 July 2007

Acceptance publication date 28 July 2011

International Classifications

C07D 239/84 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 239/95 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/076092 Priority application(s): WO2007/076092

28 July 2011 Application Accepted

  Published as AU-B-2006330888

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006330898-Carton with handle

2006330883-3-aryl-substituted quinazolones, and uses thereof